Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer.
J Exp Clin Cancer Res. 2023 Nov 28;42(1):325. doi: 10.1186/s13046-023-02903-x.
J Exp Clin Cancer Res. 2023.
PMID: 38017459
Free PMC article.
Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer.
Jeong YG, Katuwal NB, Kang MS, Ghosh M, Hong SD, Park SM, Kim SG, Kim TH, Moon YW.
Jeong YG, et al.
Cancers (Basel). 2023 Oct 8;15(19):4887. doi: 10.3390/cancers15194887.
Cancers (Basel). 2023.
PMID: 37835582
Free PMC article.
Item in Clipboard
PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer.
Ghosh M, Kang MS, Katuwal NB, Hong SD, Jeong YG, Park SM, Kim SG, Moon YW.
Ghosh M, et al.
Int J Mol Sci. 2023 Dec 3;24(23):17086. doi: 10.3390/ijms242317086.
Int J Mol Sci. 2023.
PMID: 38069409
Free PMC article.
Item in Clipboard
Combination of Abemaciclib following Eribulin Overcomes Palbociclib-Resistant Breast Cancer by Inhibiting the G2/M Cell Cycle Phase.
Pandey K, Katuwal NB, Park N, Hur J, Cho YB, Kim SK, Lee SA, Kim I, Lee SR, Moon YW.
Pandey K, et al.
Cancers (Basel). 2022 Jan 1;14(1):210. doi: 10.3390/cancers14010210.
Cancers (Basel). 2022.
PMID: 35008374
Free PMC article.
Item in Clipboard
Cite
Cite